Top Markets
Coin of the day
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Kedudukan dalam Saham #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Harga Saham
$2.72
Disegerakkan terakhir: 2023-10-19
Modal Pasaran
$111.47M
Perubahan (1 hari)
-0.73%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Talaris Therapeutics, Inc. (TALS)

Kategori

Sejarah pecahan saham untuk Talaris Therapeutics, Inc. (TALS)
Saham Talaris Therapeutics, Inc. (simbol: TALS) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 23, 2026.
Satu saham TALS yang dibeli sebelum Aug 23, 2026 kini bersamaan dengan 0 saham TALS.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH